mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0008 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |